NDC 68982-810

Cutaquig

Immunoglobulin G

Cutaquig is a Subcutaneous Solution in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is Human Immunoglobulin G.

Product ID68982-810_1034d029-04d1-1503-9c99-050051595669
NDC68982-810
Product TypePlasma Derivative
Proprietary NameCutaquig
Generic NameImmunoglobulin G
Dosage FormSolution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2019-05-03
Marketing CategoryBLA / BLA
Application NumberBLA125668
Labeler NameOctapharma USA Inc
Substance NameHUMAN IMMUNOGLOBULIN G
Active Ingredient Strength165 mg/mL
Pharm ClassesHuman Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68982-810-01

1 VIAL, GLASS in 1 CARTON (68982-810-01) > 6 mL in 1 VIAL, GLASS (68982-810-81)
Marketing Start Date2019-05-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68982-810-81 [68982081081]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-83 [68982081083]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-03 [68982081003]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-01 [68982081001]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-02 [68982081002]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-86 [68982081086]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-05 [68982081005]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-04 [68982081004]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-85 [68982081085]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-82 [68982081082]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-84 [68982081084]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

NDC 68982-810-06 [68982081006]

Cutaquig SOLUTION
Marketing CategoryBLA
Application NumberBLA125668
Product TypeLOT DISTRIBUTION DATA
Billing UnitML
Marketing Start Date2019-05-03

Drug Details

Active Ingredients

IngredientStrength
HUMAN IMMUNOGLOBULIN G165 mg/mL

Pharmacological Class

  • Human Immunoglobulin G [EPC]
  • Passively Acquired Immunity [PE]
  • Antigen Neutralization [MoA]
  • Immunoglobulins [CS]

NDC Crossover Matching brand name "Cutaquig" or generic name "Immunoglobulin G"

NDCBrand NameGeneric Name
0069-1061Cutaquigimmunoglobulin G
0069-1476Cutaquigimmunoglobulin G
0069-1509Cutaquigimmunoglobulin G
0069-1802Cutaquigimmunoglobulin G
0069-1960Cutaquigimmunoglobulin G
0069-1965Cutaquigimmunoglobulin G
68982-810Cutaquigimmunoglobulin G

Trademark Results [Cutaquig]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CUTAQUIG
CUTAQUIG
87225330 5880441 Live/Registered
Octapharma AG
2016-11-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.